Literature DB >> 1864955

Differential effects of microenvironmentally presented interleukin 3 versus soluble growth factor on primitive human hematopoietic cells.

T Otsuka1, J D Thacker, C J Eaves, D E Hogge.   

Abstract

The effect of IL-3 on hematopoiesis in long-term culture (LTC) was studied by cocultivating normal human marrow cells with human marrow fibroblast feeders engineered to constitutively produce IL-3 and by adding soluble IL-3 to LTC according to a variety of dose-time schedules. Feeders stably producing 7 ng/ml IL-3, or LTC to which 10 ng/ml IL-3 was added daily for 5 wk, but not once or twice weekly for the same time period, increased the output of mature nonadherent cells and progenitors from LTC as compared to control cultures. At the time of the weekly half-medium change, when primitive clonogenic progenitors in the adherent layer of standard LTC are quiescent, such cells were actively cycling in cultures containing a continuous source of an adequate dose of IL-3. In LTC, where the proportion of IL-3-producing cells in the feeder layer was diluted to 10% and no IL-3 was detectable in culture medium, primitive adherent layer progenitors were, nevertheless, maintained as a population of continuously proliferating cells. Thus, the presence of IL-3 in LTC can enhance the proliferation and differentiation of very early human hematopoietic cells, but the concentration, duration of exposure, and method of IL-3 presentation are important determinants of the ultimate effects observed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864955      PMCID: PMC295347          DOI: 10.1172/JCI115320

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

Review 1.  The granulocyte-macrophage colony-stimulating factors.

Authors:  D Metcalf
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

2.  Truncation of the c-myb gene by a retroviral integration in an interleukin 3-dependent myeloid leukemia cell line.

Authors:  Y Weinstein; J N Ihle; S Lavu; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis.

Authors:  R Roberts; J Gallagher; E Spooncer; T D Allen; F Bloomfield; T M Dexter
Journal:  Nature       Date:  1988-03-24       Impact factor: 49.962

4.  Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro.

Authors:  H J Sutherland; C J Eaves; A C Eaves; W Dragowska; P M Lansdorp
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

5.  Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features.

Authors:  G C Avanzi; P Lista; B Giovinazzo; R Miniero; G Saglio; G Benetton; R Coda; G Cattoretti; L Pegoraro
Journal:  Br J Haematol       Date:  1988-07       Impact factor: 6.998

6.  Tissue transplantation as an analytic and therapeutic tool in hereditary anemias.

Authors:  S E Bernstein
Journal:  Am J Surg       Date:  1970-04       Impact factor: 2.565

7.  Effects of recombinant human interleukin-3 in aplastic anemia.

Authors:  A Ganser; A Lindemann; G Seipelt; O G Ottmann; M Eder; S Falk; F Herrmann; J P Kaltwasser; P Meusers; M Klausmann
Journal:  Blood       Date:  1990-10-01       Impact factor: 22.113

8.  Differential and synergistic effects of human granulocyte-macrophage colony-stimulating factor and human granulocyte colony-stimulating factor on hematopoiesis in human long-term marrow cultures.

Authors:  D E Hogge; J D Cashman; R K Humphries; C J Eaves
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113

9.  The roles of granulocyte-macrophage colony-stimulating factor and interleukin 3 in stromal cell-mediated hemopoiesis in vivo.

Authors:  J F Eliason; B Thorens; V Kindler; P Vassalli
Journal:  Exp Hematol       Date:  1988-05       Impact factor: 3.084

10.  Gene expression in mice after high efficiency retroviral-mediated gene transfer.

Authors:  M A Eglitis; P Kantoff; E Gilboa; W F Anderson
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

View more
  3 in total

1.  Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures.

Authors:  P F Hughes; J D Thacker; D Hogge; H J Sutherland; T E Thomas; P M Lansdorp; C J Eaves; R K Humphries
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

2.  Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11.

Authors:  R G Hawley; T S Hawley; A Z Fong; C Quinto; M Collins; J P Leonard; S J Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

3.  Drug target optimization in chronic myeloid leukemia using innovative computational platform.

Authors:  Ryan Chuang; Benjamin A Hall; David Benque; Byron Cook; Samin Ishtiaq; Nir Piterman; Alex Taylor; Moshe Vardi; Steffen Koschmieder; Berthold Gottgens; Jasmin Fisher
Journal:  Sci Rep       Date:  2015-02-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.